Literature DB >> 23552580

Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women.

M Baldassarre1, F A Giannone, M P Foschini, C Battaglia, P Busacchi, S Venturoli, M C Meriggiola.   

Abstract

To date, the effects of long-term testosterone (T) administration on the human vagina are not completely understood. Thus, the aim of this study was to investigate the effects of long-term T treatment on vaginal tissue histology, estrogen receptor alpha (ERα) and beta (ERβ) expression and proliferation in female to male transsexual subjects (FtM). We compared vaginal samples from FtM subjects with those of premenopausal women (PrM) and postmenopausal women (M) not receiving any hormonal treatment for at least 2 years. Vaginal tissue samples from 16 FtM subjects treated with T (intramuscular injections of 100 mg Testoviron Depot/7-10 days for at least 1 year), undergoing sex reassignment surgery, and 16 PrM and 16 M subjects undergoing a vaginal hysterectomy for prolapse, were collected. For each sample, morphology, glycogen content, proliferation (ki-67), ERα and ERβ expression were evaluated. Vaginal samples from FtM showed a loss of normal architecture of the epithelium, intermediate and superficial layers were completely lost, and glycogen content was depleted. T administration resulted in a strong proliferation reduction when compared with both M and PrM subjects. Stromal and epithelial ERα as well as ERβ were significantly decreased in FtM when compared with PrM subjects. In conclusion, our data suggests that systemic T administration at supraphysiological dosage, determines profound changes in histomorphology and reduces ERs expression and proliferation of vaginal epithelium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552580     DOI: 10.1038/ijir.2013.9

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  8 in total

Review 1.  Gender differences, aging and hormonal status in mucosal injury and repair.

Authors:  Irina Grishina; Anne Fenton; Sumathi Sankaran-Walters
Journal:  Aging Dis       Date:  2014-04-01       Impact factor: 6.745

Review 2.  Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians.

Authors:  Jennifer Potter; Sarah M Peitzmeier; Ida Bernstein; Sari L Reisner; Natalie M Alizaga; Madina Agénor; Dana J Pardee
Journal:  J Gen Intern Med       Date:  2015-07-10       Impact factor: 5.128

3.  Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.

Authors:  Alison M Berner; Dean J Connolly; Imogen Pinnell; Aedan Wolton; Adriana MacNaughton; Chloe Challen; Kate Nambiar; Jacob Bayliss; James Barrett; Christina Richards
Journal:  Br J Gen Pract       Date:  2021-07-29       Impact factor: 6.302

4.  Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals.

Authors:  Jamie D Weinand; Joshua D Safer
Journal:  J Clin Transl Endocrinol       Date:  2015-06

Review 5.  Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model.

Authors:  Joshua Sterling; Maurice M Garcia
Journal:  Transl Androl Urol       Date:  2020-12

Review 6.  The Effect of Gender-Affirming Medical Care on the Vaginal and Neovaginal Microbiomes of Transgender and Gender-Diverse People.

Authors:  Yonah Krakowsky; Emery Potter; Jason Hallarn; Bern Monari; Hannah Wilcox; Greta Bauer; Jacques Ravel; Jessica L Prodger
Journal:  Front Cell Infect Microbiol       Date:  2022-01-21       Impact factor: 5.293

Review 7.  The impact of biological sex on diseases of the urinary tract.

Authors:  Léa Deltourbe; Livia Lacerda Mariano; Teri N Hreha; David A Hunstad; Molly A Ingersoll
Journal:  Mucosal Immunol       Date:  2022-07-22       Impact factor: 8.701

8.  A physiologically relevant, estradiol-17β [E2]-responsive in vitro tissue-engineered model of the vaginal epithelium for vaginal tissue research.

Authors:  Sarah Shafaat; Naside Mangir; Christopher Chapple; Sheila MacNeil; Vanessa Hearnden
Journal:  Neurourol Urodyn       Date:  2022-03-21       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.